Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 May 1.

Published in final edited form as: Virology. 2021 Feb 9;557:23–33. doi: 10.1016/j.virol.2020.12.014

Table 1.

PEG treatment restores infectivity of RCMV lacking R116.

	# plaques		Fold increase with PEG^a
	No treatment	PEG	Fold increase with PEG^a
Control siRNA	725 +/− 199	2417 +/− 736	3.3
R116–308	158 +/− 143^b	1950 +/− 421^c	12.3
R116–520	208 +/− 174^d	2183 +/− 640^e	10.5

^a

=PEG treatment increases infectivity for all siRNA (p<0.005)

^b,d

=siRNA to R116 decreases infectivity vs. control (p<0.0003, p<0.0008 respectively)

^c,e

=PEG restores infectivity of RCMV lacking R116 to control levels (p=0.21, p=0.57 respectively)